Suppr超能文献

在高效抗逆转录病毒治疗(HAART)时代,对美国佐治亚州一个囚犯队列中按艾滋病毒感染状况划分的癌症发病率和死亡率进行回顾性队列研究。

Retrospective cohort study of cancer incidence and mortality by HIV status in a Georgia, USA, prisoner cohort during the HAART era.

作者信息

Zlotorzynska Maria, Spaulding Anne C, Messina Lauren C, Coker Daniella, Ward Kevin, Easley Kirk, Baillargeon Jacques, Mink Pamela J, Simard Edgar P

机构信息

Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.

University of Texas Medical Branch, Galveston, Texas, USA.

出版信息

BMJ Open. 2016 Apr 11;6(4):e009778. doi: 10.1136/bmjopen-2015-009778.

Abstract

OBJECTIVE

Non-AIDS-defining cancers (NADCs) have emerged as significant contributors to cancer mortality and morbidity among persons living with HIV (PLWH). Because NADCs are also associated with many social and behavioural risk factors that underlie HIV, determining the extent to which each of these factors contributes to NADC risk is difficult. We examined cancer incidence and mortality among persons with a history of incarceration, because distributions of other cancer risk factors are likely similar between prisoners living with HIV and non-infected prisoners.

DESIGN

Registry-based retrospective cohort study.

PARTICIPANTS

Cohort of 22,422 persons incarcerated in Georgia, USA, prisons on 30 June 1991, and still alive in 1998.

OUTCOME MEASURES

Cancer incidence and mortality were assessed between 1998 and 2009, using cancer and death registry data matched to prison administrative records. Age, race and sex-adjusted standardised mortality and incidence ratios, relative to the general population, were calculated for AIDS-defining cancers, viral-associated NADCs and non-infection-associated NADCs, stratified by HIV status.

RESULTS

There were no significant differences in cancer mortality relative to the general population in the cohort, regardless of HIV status. In contrast, cancer incidence was elevated among the PLWH. Furthermore, incidence of viral-associated NADCs was significantly higher among PLWH versus those without HIV infection (standardised incidence ratio=6.1, 95% CI 3.0 to 11.7, p<0.001).

CONCLUSIONS

Among PLWH with a history of incarceration, cancer incidence was elevated relative to the general population, likely related to increased prevalence of oncogenic viral co-infections. Cancer prevention and screening programmes within prisons may help to reduce the cancer burden in this high-risk population.

摘要

目的

非艾滋病定义性癌症(NADCs)已成为导致HIV感染者(PLWH)癌症死亡率和发病率的重要因素。由于NADCs还与许多构成HIV基础的社会和行为风险因素相关,因此很难确定这些因素中每个因素对NADC风险的贡献程度。我们研究了有监禁史者的癌症发病率和死亡率,因为感染HIV的囚犯和未感染HIV的囚犯之间其他癌症风险因素的分布可能相似。

设计

基于登记处的回顾性队列研究。

参与者

1991年6月30日被关押在美国佐治亚州监狱且在1998年仍存活的22422人队列。

观察指标

利用与监狱行政记录匹配的癌症和死亡登记数据,评估1998年至2009年期间的癌症发病率和死亡率。针对艾滋病定义性癌症、病毒相关的NADCs和非感染相关的NADCs,按HIV状态分层,计算相对于一般人群的年龄、种族和性别调整后的标准化死亡率和发病率比值。

结果

无论HIV状态如何,该队列中相对于一般人群的癌症死亡率均无显著差异。相比之下,PLWH中的癌症发病率有所升高。此外,PLWH中病毒相关的NADCs发病率显著高于未感染HIV者(标准化发病率比值=6.1,95%CI 3.0至11.7,p<0.001)。

结论

在有监禁史的PLWH中,癌症发病率相对于一般人群有所升高,这可能与致癌病毒合并感染的患病率增加有关。监狱内的癌症预防和筛查项目可能有助于减轻这一高危人群的癌症负担。

相似文献

7
Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
Lancet HIV. 2018 Nov;5(11):e647-e655. doi: 10.1016/S2352-3018(18)30179-6. Epub 2018 Sep 21.
9
HIV infection and the risk of cancers with and without a known infectious cause.
AIDS. 2009 Nov 13;23(17):2337-45. doi: 10.1097/QAD.0b013e3283319184.

引用本文的文献

1
Examining inequities associated with incarceration among breast cancer patients.
Cancer Med. 2024 Aug;13(15):e7428. doi: 10.1002/cam4.7428.
2
Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Distinguishing Lung Cancer in People with HIV.
Dis Markers. 2024 Jan 23;2024:8822024. doi: 10.1155/2024/8822024. eCollection 2024.
3
Cancer incidence among incarcerated and formerly incarcerated individuals: A statewide retrospective cohort study.
Cancer Med. 2023 Jul;12(14):15447-15454. doi: 10.1002/cam4.6162. Epub 2023 May 29.
4
Incarceration status and cancer mortality: A population-based study.
PLoS One. 2022 Sep 16;17(9):e0274703. doi: 10.1371/journal.pone.0274703. eCollection 2022.
6
Risk of prostate cancer in men with HIV/AIDS: a systematic review and meta-analysis.
Prostate Cancer Prostatic Dis. 2021 Mar;24(1):24-34. doi: 10.1038/s41391-020-00268-2. Epub 2020 Aug 14.
7
Monomorphic ventricular tachycardia due to protease inhibitor intoxication by atazanavir.
Clin Exp Emerg Med. 2018 Jun;5(2):131-134. doi: 10.15441/ceem.17.229. Epub 2018 Apr 30.

本文引用的文献

2
Cancer treatment disparities in HIV-infected individuals in the United States.
J Clin Oncol. 2014 Aug 1;32(22):2344-50. doi: 10.1200/JCO.2013.54.8644. Epub 2014 Jun 30.
3
Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men.
J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):495-502. doi: 10.1097/QAI.0000000000000202.
4
Hepatitis C seroprevalence among prison inmates since 2001: still high but declining.
Public Health Rep. 2014 Mar-Apr;129(2):187-95. doi: 10.1177/003335491412900213.
5
Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study.
Am J Epidemiol. 2013 Sep 15;178(6):877-84. doi: 10.1093/aje/kwt153. Epub 2013 Jul 30.
6
Invited commentary: Biological and clinical insights from epidemiologic research into HIV, HPV, and anal cancer.
Am J Epidemiol. 2013 Sep 15;178(6):885-7. doi: 10.1093/aje/kwt149. Epub 2013 Jul 30.
8
Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals.
AIDS. 2013 Jan 28;27(3):459-68. doi: 10.1097/QAD.0b013e32835ad56e.
9
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.
Lancet Oncol. 2012 Jun;13(6):607-15. doi: 10.1016/S1470-2045(12)70137-7. Epub 2012 May 9.
10
Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America.
Clin Infect Dis. 2012 Apr;54(7):1026-34. doi: 10.1093/cid/cir1012. Epub 2012 Jan 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验